Document:

exv10w7

Exhibit
10.7

June 14,2010

Joseph L.
Cowan
5212 Legends Dr
Braselton, GA 30517-4012

Dear Joe,

     On behalf of Online Resources Corporation (the “Company”) and its Board of Directors (the
“Board”) I am pleased to offer you the position of President and Chief Executive Officer of the
Company, subject to the terms and conditions of this letter agreement (the “Letter Agreement”).
Upon acceptance of this offer and satisfaction of any conditions herein, you will also be
nominated to serve as a member of the Board.

     1. Position: Duties.

     (a) Your employment with the Company will commence on June 15, 2010 (the
“Effective Date”). You will be the President and Chief Executive Officer of the
Company, reporting to the Board, and will perform such duties and responsibilities commensurate
with your position as may be determined from time to time by the Board. Your primary office
will be located at the Company’s headquarters in Chantilly, Virginia; provided,
however, that in the performance of your duties and responsibilities you will be expected to travel as
needed in connection with the Company’s businesses. You agree to be bound by the policies and
procedures of the Company as in effect from time to time relating to the conduct of
employees.

     (b) By signing this Letter Agreement, you represent and warrant to the Company, as
of the date hereof and as of the Effective Date, that you are not under, subject to or
otherwise obligated by any contractual commitments (including, without limitation, any
non-competition, non-solicitation, proprietary information and inventions, shareholders’, investors’ or
similar agreements) that will be inconsistent with your obligations to the Company or that
would be breached by or would prevent or interfere with your execution of this Letter Agreement
or your obligations under this Letter Agreement to the Company.

     2. Salary. You shall be paid a salary at the annual rate of Five Hundred Thousand
and 00/100 Dollars ($500,000.00) (the “Base Salary”), payable in accordance with the Company’s
standard payroll practices for salaried employees. The Base Salary shall be reviewed by the
Management Development and Compensation Committee of the Board (the “MD&C Committee”) based upon your
performance not less often than annually. However, your Base Salary cannot be decreased
without mutual agreement between you and the MD&C Committee.

     3. Performance Bonus. During your employment with the Company, you shall be eligible
to receive an annual performance bonus (the “Performance Bonus”) under the Company’s Annual
Incentive Plan (or a successor plan, if any) (the “Annual Incentive Plan”), in accordance with
such terms and conditions as may be in effect from time to time, and, as applicable, consistent with the
terms and conditions applicable to other senior executives of the Company. Your Performance Bonus shall
have a

 

 

target amount of One Hundred Percent (100%) of your Base Salary, and a maximum amount of One
Hundred Fifty Percent (150%) of your Base Salary, subject to the achievement of certain
performance goals and objectives (the “Performance Goals”) and such other terms and conditions as
may be established from time to time by the MD&C Committee.

     Notwithstanding the foregoing, your Performance Bonus for 2010, if any, shall be subject to
the achievement of the Performance Goals for 2010 that have previously been established by the
MD&C Committee for other senior executives of the Company and the amount of the Performance Bonus
payable to you will be pro-rated based on the period of your employment from the Effective Date
through December 31, 2010, In addition, your Performance Bonus for 2010, if any, shall be paid to
you no later than December 31, 2010, based on the interim results of the applicable Performance
Goals as of the date payment is made; provided, however, that such payment will be subject
to adjustment (either upwards or downwards) at the time that Performance Bonuses for 2010, if any,
would generally be paid to employees under the Annual Incentive Plan based on the final results of
the Performance Goals, as certified by the MD&C Committee.

	4.	 	Equity Awards. Upon your commencement of employment, it shall be recommended to
the Board that you be granted the following equity awards:

     (a) Equity Incentive Awards. In connection with your employment with the
Company for 2010, you shall be granted on the second business day following the
Effective Date that number of (i) options to purchase shares of common stock of the Company (the
“Common Stock”) with a value, measured as of the grant date, equal to $750,000 (based on Black
Scholes option pricing methodology) (the “Stock Options”) and (ii) restricted shares of Common
Stock with a value, measured as of the grant date, equal to $1,000,000 (the “Restricted
Stock”) on such terms and conditions as set forth in an award agreement consistent the terms of this
Letter Agreement and the other terms generally applicable to the senior executives of the
Company. The Stock Options shall have an exercise price equal to the closing price of a share of
Common Stock on the grant date. The Stock Options and Restricted Stock shall vest on a pro
rata basis in four substantially equal installments commencing on the first anniversary of the
Effective Date, subject to your continued employment with the Company through each applicable vesting
date. Subject to the terms and conditions of the applicable award agreements and this Letter
Agreement, in the event of the termination of your employment or resignation, any
outstanding unvested Stock Options and Restricted Stock then held by you will be automatically
forfeited and cancelled as of the date of your termination of employment or resignation, as the case
may be, without payment to you. During your employment with the Company after 2010, you shall
be eligible to receive an annual grant of equity-based awards under the Company’s 2005
Amended and Restated Restricted Stock and Option Plan (or a successor plan, if any) (the
“Equity Plan”), in accordance with such terms and conditions as may be in effect from time to time,
and, as applicable, consistent with the terms and conditions applicable to other senior
executives of the Company. The amount and size of any subsequent grants will be determined in the
discretion of the MD&C Committee based on such factors and conditions as it deems appropriate
(including, without limitation, the amount and size of prior equity-based awards made to you any
and benchmark compensation studies undertaken by the MD&C Committee).

     (b) Share Purchase. In connection with your employment with the Company, on
the second business day following the Effective Date (the “Purchase Date”), you will
purchase from the Company in a private transaction that number of shares of Common Stock (the
“Purchased Shares”) with a value, equal to $500,000 based on the closing price of the
Common Stock on Purchase Date as reported on NASDAQ (the “Share Purchase”). In connection
with the Share Purchase, you shall be granted on the Purchase Date a number of shares of
Common

2

 

Stock equal to the number of Purchased Shares (the “Company Match Shares”). The Company
Match Shares shall folly vest on the nine-month anniversary of the Purchase Date. In the
event of the termination of your employment or resignation, any outstanding unvested Company
Match Shares then held by you will be automatically forfeited and cancelled as of the date
of your termination of employment or resignation, as the case may be, without payment to
you. Notwithstanding the foregoing, you may not sell, transfer, pledge, assign or otherwise
dispose of the Company Match Shares and the Purchased Shares until after your termination of
employment or resignation, as the case may be, and in any event in accordance with
applicable Company policies. The terms and conditions of the Share Purchase and the Company
Match Shares will be set forth in a share purchase agreement and in an award agreement
consistent the terms of this Letter Agreement and the other terms generally applicable to
the senior executives of the Company for similar awards.

     5. Other Benefits. During your employment with the Company, you shall be eligible to
participate in the Company employee benefit plans and arrangements made available to senior
executives of the Company, including, without limitation, paid vacation time of no less than 20 days per
calendar year (or a proportionate number of days for any calendar year in which you are employed for a
period less than a full calendar year) plus the number of regular holidays and sick days granted to
Company employees, in accordance with the terms and conditions applicable to other senior executives.
Except as otherwise specified in this Letter Agreement, such plans are subject to change or termination
from time to time at the discretion of the Board.

     6. General Expense Reimbursement. During your employment with the Company, the
Company shall reimburse you for all reasonable business-related expenses that you incur on the
Company’s behalf, in accordance with the standard policies and procedures established by the
Company as in effect from time to time. In addition, the Company shall provide you with up to
$36,000 per calendar year (pro rated for the period in which you are employed in 2010) for reasonable
costs and expenses that you may incur for temporary housing and automobile expenses, in accordance with
the standard policies and procedures established by the Company as in effect from time to time.

     7. Termination of Employment.

     (a) Employment at Will. You are being offered employment with the Company for
an unspecified period of time and this Letter Agreement will create an at-will employment
relationship that may be terminated by you or the Company at any time and for any reason.

     (b) Termination of Employment other than for Cause or for Good Reason. Subject
to the provisions of this Letter Agreement and except in the event of your termination
on or after a Change in Control as provided in Paragraph 7(c), if your employment with the Company
(A) is terminated by the Company for any reason other than (I) for “Cause” (as defined in
Exhibit A) or (II) as a result of your “Disability” (as defined in Exhibit A); or (B) is terminated
by you for Good Reason (as defined in Exhibit A), your severance benefits shall be as follows:

     (i) Severance payment. On the first regular payroll date concurrent
with or following the date that is thirty (30) days after your “Date of Termination”
(as defined in Exhibit A), the Company shall make a single-sum cash payment to you
in an amount equal to the product of (A) the sum of (x) your average annual Base
Salary for the three complete fiscal years of the Company immediately preceding the
fiscal year in which the Date of Termination occurs, plus (y) your average
annual cash bonus target for the three complete fiscal years of the Company
immediately preceding the fiscal year in which the Date of Termination occurs, times
(B) the ratio, the numerator of which is the number of

3

 

months in the “Severance Period” (as defined in Exhibit A) and the denominator of which is
12. In the event that you are not employed by the Company for three complete fiscal years
preceding the fiscal year in which the Date of Termination occurs, your Base Salary and
annual cash bonus target for the period of your employment will be used to determine such
average amounts, provided that if you are employed by the Company for less than one
complete fiscal year, your Base Salary and annual cash bonus target for such fiscal year
will be annualized. In addition, within 90 days after the end of the fiscal year in which
the Date of Termination occurs, the Company shall make a single-sum cash payment to you in
the amount equal to the product of (x) the cash bonus that you would have received for the
fiscal year in which the Date of Termination occurred had no termination occurred, based
upon the amount accrued for such bonus for financial statement accounting purposes,
times (y) the ratio, the numerator of which is the number of days in the fiscal
year in which the Date of Termination occurred during which you were employed and the
denominator of which is 365.

     (ii) Vesting of Equity Awards. Any outstanding stock options, restricted
stock or other equity awards (the “Equity Awards”) that have been made to you under any
equity compensation plan of the Company or otherwise that have not already vested (but, in
any event, not including the Company Match Shares, which vest pursuant to Paragraph 4(b),
hereinabove) shall continue to vest and become non-forfeitable as if you had remained
employed during the Severance Period; and

     (iii) Continued Benefit Coverage. If you timely elect to continue coverage
under the Company’s health benefit plan (including medical, dental and vision insurance)
pursuant to the continuation provisions of the Internal Revenue Code of 1986, as amended
(the “Code”) and ERISA (“COBRA”), for the duration of the period during which you keep the
COBRA continuation coverage in effect, or, if shorter, the Severance Period, the maximum
premium yqu will be required to pay for any month of coverage will be the premium charged
to active employees of the Company for comparable coverage.

     (iv) Release of Claims. Notwithstanding the foregoing provisions of this
Paragraph 7(b), and as a condition precedent to the Company’s obligations thereunder, not
later than the payment date described in Paragraph 7(b)(i), you shall provide the Company
a valid, executed, general release of claims in the form attached as Exhibit B, and such
release shall have not been revoked and shall have become effective in accordance with its
terms.

     (c) Termination of Employment Following a Change of Control. Subject to the provisions of
this Letter Agreement, if your employment with the Company is terminated on or after a Change in
Control under the circumstances set forth below, your entitlement to any severance benefits shall
be as follows:

     (i) Severance Benefits, In the event your employment with the Company is
terminated during the period beginning on the date of a Change in Control and ending on
the twelve (12) month anniversary of the date of such Change in Control 0) by the Company
other than for “Cause” (as defined in Exhibit A) or as a result of your “Disability” (as
defined in Exhibit A) or (II) by you for “Good Reason” (as defined in Exhibit A), the
Company shall pay or provide you with the following payments and other compensation:

4

 

     (A) Severance Payment. Within thirty (30) days after your “Date of Termination” (as defined
in Exhibit A), the Company shall make a single-sum cash payment to you in an amount equal to the
sum of (i) 1.5 times your average annual base salary for the three complete fiscal years of the
Company immediately preceding the fiscal year in which the Date of Termination occurs,
plus (ii) 1.5 times your average annual cash bonus target for the three complete fiscal
years of the Company immediately preceding the fiscal year in which the Date of Termination
occurs. In the event that you are not employed by the Company for three complete fiscal years,
your base salary and annual cash bonus target for the period of your employment will be used,
provided that if you are employed by the Company for less than one complete fiscal year,
your base salary and annual cash bonus target for such fiscal year will be annualized. In
addition, within 90 days after the end of the fiscal year in which the Date of Termination occurs,
the Company shall make a single-sum cash payment to you in the amount equal to the product of (x)
the cash bonus that you would have received for the fiscal year in which the Date of Termination
occurred had no termination occurred, based upon the amount accrued for such bonus for financial
statement accounting purposes, times (y) the ratio, the numerator of which is the number
of days in the fiscal year in which the Date of Termination occurred during which you were
employed and the denominator of which is 365.

     (B) Vesting of Equity Awards. Notwithstanding any provisions of this Letter Agreement or any
plans or other agreements to the contrary, in the event that your Date of Termination following a
Change in Control occurs on or after the twelve (12) month anniversary of the Effective Date, any
outstanding stock options, restricted stock or other equity awards (the “Equity Awards”) that have
been made to you under any equity compensation plan of the Company (but, in any event, not
including the Company Match Shares) shall vest and become non-forfeitable as follows: (I) if the
per-share price at which the Common Stock is sold by the Company in the transaction constituting
the Change in Control (or, if no Common Stock is sold by the Company in the such transaction, the
average of the closing prices of the Common Stock as reported on NASDAQ on the 30 trading days next
preceding the date of the Change in Control) (the “Share Price”) is equal to less than $7 per
share, fifty (50%) percent of your then outstanding unvested Equity Awards shall vest; (II) if the
Share Price is equal to or more than $9 per share, one hundred (100%) percent of your then
outstanding unvested Equity Awards shall vest; and (III) if the Share Price is between $7.00 per
share and $9.00 per share, the percentage of your then outstanding unvested Equity Awards that
shall vest will be interpolated on a straight line basis between fifty (50%) percent and one
hundred (100%) percent.

     (C) Continued Benefit Coverage. If you timely elect to continue coverage under the Company’s
health benefit plan (including medical, dental and vision insurance) pursuant to the provisions of
continuation provisions of the Internal Revenue Code of 1986, as amended (the “Code”) and ERISA
(“COBRA”), for the duration of the period during which you keep the COBRA continuation coverage in
effect, or, if shorter, for 18 months, the maximum premium you will be required to pay for any
month of coverage will be the premium charged to active employees of the Company for comparable
coverage.

5

 

     (ii) Section 280G of the Code.

     (A) In the event that it is determined that the severance benefit
payable to you pursuant to Paragraph 7(c)(i), when added to any other payment
or benefit to you from the Company that would be considered a “parachute
payment” (a “Parachute Payment”), within the meaning of Section 280G of the
Code, would cause you to be considered to receive an “excess parachute
payment” within the meaning of Section 280G of the Code (an “Excess
Parachute Payment”), the amount payable to you pursuant to Paragraph 7(c)(i)
will be reduced to the maximum amount that, when added to any other Parachute
Payments made to you, could be paid to you without causing you to receive an
Excess Parachute Payment. Notwithstanding the foregoing, the severance benefit
payable to you pursuant to Paragraph 7(c)(i) will not be reduced if (I) the
net amount payable to you without the reduction described in the preceding
sentence, but reduced by all Federal, state and local income and employment taxes
payable by you on the severance benefit payable pursuant to you and all other
Parachute Payments dIus the excise tax payable on the Excess Parachute Payment
pursuant to Section 4999 of the Code, is greater than (II) the net amount that would be
payable to you with the reduction described in the preceding sentence and
reduced by all Federal, state and local income and employment taxes payable by
you on the severance benefit payable pursuant to Paragraph 7(c)(i) and all
other Parachute Payments.

     (B) For purposes of this clause (ii), you will be deemed to pay
Federal income tax and employment taxes at the highest marginal rate of
Federal income and employment taxation in the calendar year in which the Excess
Parachute Payment would occur and state and local income taxes at the highest
marginal rate of taxation in the state and locality of your residence in the
calendar year in which the Excess Parachute Payment would be made, net of the reduction
in Federal income taxes that you may obtain from the deduction of such state
and local income taxes. In addition, all determinations to be made under this
clause (ii) will be made by the Company’s independent public accountant (the
“Accounting Firm”) immediately before the date the severance benefit under
Paragraph 7(c)(i) is to be paid. The Accounting Firm will provide its
determinations and any supporting calculations and workpapers both to the
Company and to you within ten (10) days of such date, and any such determination
by the Accounting Firm will be binding upon the Company and you.

     (iii) Expense; Legal Fees. If you commence a legal action to enforce any of
the obligations of the Company under this Paragraph 7 and it is ultimately determined that
you are entitled to any payments or benefits under this Paragraph 7, the Company shall pay
you the amount necessary to reimburse you in full for all reasonable expenses (including
reasonable attorneys’ fees and legal expenses) incurred by you with respect to such action.

     (d) Notice of Termination. Any purported termination of your employment (other than by reason
of death) will be communicated by a written “Notice of Termination” (as defined in Exhibit A) from
one party to another in accordance with Paragraph 15. Notwithstanding anything to the contrary in
this Paragraph 7, no termination for Cause will be effective without
(I) reasonable notice to you setting forth the reasons for the Company’s intention to terminate,
and (II) an opportunity for you to cure or correct any such breach within twenty (20) days after
receipt

6

 

of such notice. Notwithstanding anything to the contrary in this Paragraph 7, no termination for
Good Reason will be effective unless (l)you have delivered to the Company a Notice of Termination
in accordance with this clause (iii) within thirty (30) days after the occurrence of the event or
circumstance which constitutes Good Reason, and (II) the Company has been afforded an opportunity
to cure or correct such event or circumstance within twenty (20) days after receipt of such notice.

     (e) No Mitigation. Your right to the severance benefit payable pursuant to
Paragraph 7 is not subject to any requirement that you seek other employment or otherwise
attempt in any way to reduce any amounts payable to you pursuant to Paragraph 7. Further, the
amount payable to you shall not be reduced by any compensation or income earned by you as the
result of employment by another employer or self-employment, by retirement benefits, by offset
against any amount claimed to be owed by you to the Company, or otherwise.

     (f) Effect of Termination. The termination of your employment for any reason will
constitute your resignation from (i) any director, officer or employee position you have with
the Company or any affiliate thereof and (ii) all fiduciary positions (including as a trustee) you
hold with respect to any employee benefit plans or trusts established by the Company or any
affiliate thereof. You hereby agree that this Letter Agreement will serve as written notice of
resignation in this circumstance.

     8. Outside Activities.

     (a) Exclusive Services. During your employment with the Company, you agree to
devote substantially all of your professional time, attention and efforts to the performance
of your duties under this Letter Agreement, and will not render services to any other business without
the written consent of the Board. You may serve on civic or charitable boards or engage in
charitable activities without remuneration therefor subject to the prior approval of the Board, which
shall not be unreasonably withheld. The Company recognizes that you serve as a member of the board
of directors of Blackboard Corporation and consents to your continued service on that board.
The Board, however, reserves the right to require you to resign from any board or similar body on
which you may serve, if it determines in good faith that your service on such board interferes
with the effective discharge of your duties and responsibilities to the Company as contemplated by
Paragraph l(a) or that any business related to such service contravenes the requirements of
Paragraph 8(b) or the Confidentiality and Non-Disclosure Agreement (as set forth in Paragraph 9).
In addition, you will not own, directly or indirectly, any capital stock of any company
which is in competition with any line of business conducted by the Company or its affiliates;
provided, however, that you may own, directly or indirectly, up to one percent (1%) of the
outstanding capital stock of any publicly traded corporation.

     (b) Non-Competition. During your employment and for twelve (12) months
following your termination of employment or resignation for any reason, you will not, directly
or indirectly, engage in (whether as an employee, consultant, agent, advisor, proprietor,
principal, partner, stockholder, corporate officer, director or otherwise), nor have any direct or
indirect ownership interest in, or directly or indirectly participate in the financing, operation,
management or control of, any person, firm, corporation or business that is engaged in providing web- and
phone-based payment services to financial institution, biller, card issuer and creditor
clients (a “Competing Business”); provided that you may purchase and hold only for investment
purposes less than one percent (1%) of the shares of any corporation in a Competing Business whose
shares are regularly traded on a national securities exchange.

7

 

     (c)
Non-Solicitation. During
your employment and for twenty-four (24) months following your termination of employment or resignation for
any reason, you will not, directly or indirectly, induce or attempt to induce any customer,
client, supplier, licensee or other person or entity then having a business relationship with the Company
or any of its affiliates (collectively, the “Company Group”) to cease doing
business with any member of the Company Group, or in any way knowingly interfere with the relationship between any member of the Company Group and any customer, client, supplier, licensee or other business relationship. As used herein, the term "indirectly" will include, without limitation, the authorized use of your name by any competitor of the Company or any member of the Company Group to induce or interfere with any business relationship of the Company or any member of the Company Group.

     9. Other Covenants. In connection with your entering into this Letter Agreement, you
agree to execute and deliver to the Company the Confidentiality and Non-Disclosure Agreement
attached hereto as Annex A (the “Confidentiality and Non-Disclosure Agreement”).

     10. Material Inducement; Certain Remedies, You acknowledge and agree that the
covenants entered into by you pursuant to Paragraphs 8 and 9 are essential elements of the
parties’ agreement as expressed in this Letter Agreement, are a material inducement for the Company to
enter into this Letter Agreement and the breach of any of those covenants would be a material breach of
this Letter Agreement. You further acknowledge and agree that the Company’s remedies at law for a breach
or threatened breach of any of the provisions of Paragraph 8 or the Confidentiality and
Non-Disclosure Agreement would be inadequate. In recognition of this fact, you agree that, in the event of
such a breach or threatened breach, in addition to any remedies at law, the Company will be entitled to
obtain equitable relief in the form of temporary restraining order, temporary or permanent injunction or any
other equitable remedy which may then be available, without bond or security, restraining you from
engaging in the activities prohibited by Paragraph 8 or the Confidentiality and Non-Disclosure
Agreement, or such other relief as may be required specifically to enforce this Letter Agreement. In addition to
any other remedies that may be available to the Company, if following your termination of employment or
resignation for any reason you breach any of the provisions of Paragraphs 8 or the
Confidentiality and Non-Disclosure Agreement, the Company may cease providing you with the payments and benefits
set forth in Paragraph 7 and any and all obligations of the Company will cease.

     11. Withholding. All forms of compensation referred to in this Letter Agreement are
subject to reduction to reflect applicable withholding and payroll taxes and any other legal deduction
or withholding requirement.

     12. Section 409A of the Code.

     (a) This Letter Agreement is intended to meet the requirements of Section 409A of
the Code and will be interpreted and construed consistent with that intent. For
purposes of this Letter Agreement, the terms “terminate,” “terminated” and “termination” mean a
termination of your employment that constitute a “separation from service” within the meaning of the
default rules of Section 409A of the Code.

     (b) Notwithstanding any other provision of this Letter Agreement, to the extent that
the right to any payment (including the provision of benefits) hereunder provides for
the “deferral of compensation” within the meaning of Section 409A(d)(l) of the Code, the payment
shall be paid (or provided) in accordance with the following:

     (i) If you are a “Specified Employee” within the meaning of Section
409A(a)(2)(B)(i) of the Code on the date of your termination of employment, then no

8

 

such
payment will be made or commence during the period beginning on the
date of termination and ending on the date that is six
(6) months following the date of termination or, if earlier, on
the date of your death. The amount of any payment that would
otherwise be paid to you during this period shall instead be paid on
the fifteenth (15th) day of the first calendar month
following the end of the period.

     (ii)
For the purposes of clarification, any payments that are subject to
Section 409A of the Code will not include any payments on the
occurrence of an involuntary termination of employment that would
satisfy the short-term deferral exclusions described in
Section 1.409A-1(b)(4) of the Treasury Regulations or the
separation pay exception described in Section 1.409A-1(b)(9) of the
Treasury Regulations; and such payments shall be made to you
immediately upon your termination.

     (iii) Payments with respect to reimbursements of expenses shall be made on or
before the last day of the calendar year following the calendar year in which the
relevant expense is incurred. The amount of expenses eligible for reimbursement
during a calendar year may not affect the expenses eligible for reimbursement in any
other calendar year.

     (c) Notwithstanding any provision of this Letter Agreement to the contrary, if any
provision of this Letter Agreement contravenes any regulations or guidance promulgated
under Section 409A of the Code or would cause any person to be subject to additional taxes,
interest and/or penalties under Section 409A of the Code, such provision of this Letter
Agreement shall be deemed void ab initio and the parties shall negotiate in good faith to
replace the non-compliant provisions with compliant provisions under Section 409A of the
Code.

     13. Initial Grant of Equity Awards. The Stock Options, Restricted Stock and Company
Match Shares granted to you pursuant to Paragraph 4 will be granted outside of the Equity Plan
in accordance with NASDAQ Listing Rule 5635(c)(4) as an inducement to you to enter into
employment with the Company.

     14. Entire Agreement. This Letter Agreement, including the referrals herein to
other documents, plans and agreements, contain all of the terms of your employment with the Company
and supersede, as of the date hereof, any prior understandings or agreements, whether oral or
written, between you and the Company or its affiliates.

     15. Notices. Notices and all other communications provided for in this Letter
Agreement shall be in writing and shall be addressed, if to you, to the address on file with the Company
and, if to the Company, to the address set forth below, or to such other address as either party may have
furnished to the other in writing in accordance herewith, except that notice of change of address shall be
effective only upon actual receipt:

To the Company:

Online Resources Corporation

4795 Meadow Wood Lane

Chantilly,VA 20151

Attention: General Counsel

9

 

All such notices shall be conclusively deemed to be received and shall be effective (i) if sent by
hand delivery, upon receipt or (ii) if sent by electronic mail or facsimile, upon of receipt by the
sender of such transmission.

     16. Successors and Assigns. All covenants, promises and agreements by or on behalf of
the Company contained in this Letter Agreement will inure to the benefit of, and be binding upon,
the successors and assigns of the Company. This Letter Agreement is personal to you and will not
be assignable or delegable by you other than by will or the laws of descent and distribution.
This Letter Agreement (including any post-termination payment obligations) will inure to the benefit of
and be enforceable by your heirs (in the event of your death) and legal representatives. The
Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or
otherwise) to all or substantially all of the business and/or assets of the Company expressly to assume this
Letter Agreement and all obligations of the Company hereunder in the same manner and to the same
extent that the Company would be so obligated if no such succession had taken place.

     17. Miscellaneous.

     (a) Please be advised that your offer of employment is contingent upon the
satisfactory completion of the Company’s employee on-boarding process, including
criminal and civil background checks and drug testing.

     (b) Attorneys’ Fees. The Company shall reimburse you for reasonable attorney fees
in an amount not to exceed $5,000 incurred in negotiating and finalizing this Letter
Agreement.

     18. Amendment, Governing Law, and Venue. Subject to Paragraph 12(c), this Letter
Agreement may not be amended or modified except by an express written agreement signed by you and
a duly authorized officer of the Company. The terms of this Letter Agreement and the resolution of
any disputes will be subject to Delaware law.

10

 

     Joe, we hope that you find the foregoing terms acceptable. We are very excited to have you
join the Company. You may indicate your agreement with these terms and accept this offer by signing
and dating the enclosed duplicate original of this Letter Agreement and returning them to me.

     We look forward to having you join us.

	 	 	 	 	 
	 	Very truly yours,

 	 
	 	By:  	/s/ John Dorman	 
	 	 	Name:  	John Dorman 	 
	 	 	Title:  	Chairman of the Board 	 
	 

I have read and accept this employment offer:

	 	 	 	 	 

	/s/ Joseph L. Cowan

	 	Dated:
	 	6-15-10
	 

	 	 	 	 
	Joseph L. Cowan
	 	 	 	 

11

 

Exhibit A

Definitions

	 	 	For purposes of Paragraph 7 of the Letter Agreement, the following terms will have the
following meanings:

     “Cause” means:

     (i) acts of fraud or misappropriation committed by you and intended to result in
substantial personal enrichment at the expense of the Company;

     (ii) repeated violations by you of your obligations to the Company which are
demonstrably willful and deliberate and which result in material injury to the Company;
provided that, in each case, you have received written notice of the described activity,
have been afforded a period of 20 days to cure or correct the activity described in the
notice, and have failed to cure, correct or cease the activity, as appropriate; or

     (iii) the breach of a published Company policy that, in the opinion of counsel, had a
reasonable likelihood to expose the Company to material liability or material regulatory
noncompliance.

“Change in Control” shall mean any change in control of the Company of a nature that would
be required to be reported in response to Item l(a) of the Current Report on Form 10-K, as
in effect on the Effective Date, pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934, as amended from time to time (the “Act”); provided that, without limitation,
such a “Change in Control” shall be deemed to have occurred if:

     (i) a third person, including a “group” as such term is used in Section 13(d)(3) of
the Act, becomes the beneficial owner, directly or indirectly, of 50% or more of the
combined voting power of the Company’s outstanding voting securities ordinarily having the
right to vote for the election of directors of the Company, unless such acquisition of
beneficial ownership is approved by a majority of the Incumbent Board (as such term is
defined in clause (ii) below); or

     (ii) individuals who, as of the Effective Date, constitute the Board (the “Incumbent
Board”) cease for any reason to constitute at least a majority of the Board, provided that
any person becoming a director subsequent to the date hereof whose election, or nomination
for election by the Company’s shareholders, was approved by a vote of at least
three-quarters of the directors comprising the Incumbent Board (other than an election or
nomination of an individual whose initial assumption of office is in connection with an
actual or threatened election contest relating to the election of the Directors of the
Company, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Act)
shall be, for purposes of this provision, considered as though such person were a member of
the Incumbent Board.

“Date of Termination” means, with respect to any purported termination of your employment
(other than by reason your death or Disability), shall mean the date specified in the Notice
of Termination.

“Disability” shall mean your incapacity due to physical or mental illness to perform your
full-time duties with the Company for a continuous period of three months or an aggregate
of six months in any eighteen-month period.

A-1

 

“Good Reason” shall mean, without your consent:

     (i) any changes in your duties and responsibilities which are materially inconsistent
with your duties and responsibilities within the Company immediately prior to the Change in
Control;

     (ii) any material reduction of your salary, aggregate incentive compensation
opportunities (excluding any reduction in incentive compensation awards due to the economic
performance of the Company) or aggregate benefits;

     (iii) any required relocation of your office beyond a 50 mile radius from the location
of your office immediately prior to the Change in Control; or

     (iv) any failure by the Company to obtain the assumption of this Letter Agreement by a
successor of the Company.

“Notice of Termination” shall mean a notice which will indicate the specific nature of
termination (as set forth in the first paragraph of Paragraph 7(c)(i)) and will set forth in
reasonable detail the facts and circumstances claimed to provide a basis for the termination
of your employment under the provision so indicated.

“Severance Period” shall mean either (i) the period of 12 months following the Date of
Termination, if the Date of Termination occurs on or prior to the first anniversary of the
Effective Date, or (ii) the period of 18 months, if the Date of Termination is after such
anniversary date.

A-2exv10w12

Exhibit 10.12

	 	 	 	 	 	 

	 	 

	 	BIOCRYST PHARMACEUTICALS, INC. 

2190 PARKWAY LAKE DRIVE

BIRMINGHAM. AL 35244

205-444-4600 205-444-4640 FAX
	 	Jon P. Stonehouse

Chief Executive Officer
	 	 
	 	 	 	 
	 	 

	 	2425 KILDAIRE FARM ROAD, SUITE 106

CARY, NC 27518

919-859-1302 919-851-1416 FAX	 	 
	 	 
	 	 	 	 
	 	 

	 	www.biocryst.com	 	 

December 11,
2009

Peter McCullough

40 Manomet Ave.

Hull, MA 02045

Dear Peter:

On behalf of BioCryst Pharmaceuticals, Inc., I am pleased to extend to you a
formal invitation to join the BioCryst team as Vice President Operations. You
will report directly to the Sr. Vice President and Chief Financial Officer,
Stuart Grant.

We are projecting a start date sometime in early January 2010 (exact date to be
determined and finalized) and your compensation will consist of the following
components:

	 	1.	 	A salary rate of $10,833,33 ($260,000 annually) per semi-monthly period
payable on the
15th
and 31st of each month, subject to the
customary deductions and withholdings as required by law.
	 
	 	2.	 	In addition to the basic compensation set forth in (1) above, Employee shall
be eligible to earn a cash bonus, payable as soon as reasonably practicable in
the calendar year following each calendar year during the term of this
Agreement, based on the Company’s achievement of performance related goals
proposed by management and approved by the Board for the Company’s applicable
fiscal year (the “Fiscal Year”), and the Employee’s performance during the
year. The bonus actually earned, if any, shall be based on a target amount
equal to 25% of the base compensation, earned by executive during such Fiscal
Year (the “Target Amount”), and shall be pro-rated based on the degree to which
the performance goals have been achieved, subject to a minimum level of
achievement proposed by management and approved by the Board. The Target Amount
for the 2010 Fiscal Year shall be prorated based on Employee’s base salary as
of December 31, 2010. Employee must be employed through April 1, of the next
succeeding Fiscal Year in order to receive the annual bonus for each Fiscal
Year.

 

 

Peter McCullough

Page Two

December 11, 2009

	 	3.	 	You will be eligible to receive 70,000 shares of BioCryst stock in an employee incentive
stock option program, which the BioCryst Board of Directors has instituted. All stock option
grants are subject to the approval of the Compensation Committee and subject to the
requirements of state and federal laws. Your grant date for these options will be your start
date with the pricing being determined by the closing market price on that date.
	 
	 	 	 	The parties intend for the Option to qualify as “incentive stock options,” as that term is defined
in Section 422 of the Internal Revenue Code of 1986, as amended (“Section 422”) to the fullest
extent possible. The parties understand that the portion of the Option, together with the portion
of any other incentive stock option granted by BioCryst and its parent and subsidiary corporations,
if any, which may become exercisable in any year in excess of an aggregate of $100,000 fair market
value, determined as of the date the Option or such other option, as the case may be, was granted,
may not be treated as an incentive stock option under Section 422.
	 
	 	4.	 	You will be eligible to participate in the Company benefit programs according to the terms of
those programs. We currently have group life insurance, disability insurance (short and long
term), medical/dental insurance plans and a 401(k) retirement plan with a company match.
BioCryst pays 100% of the Employee Only premiums, and requires employees to contribute toward
the cost of dependent medical premims.
	 
	 	 	 	Our 401(k) retirement plan allows you to contribute as much as 30% of your salary. The Company
currently matches your contribution up to 5% of your salary.
	 
	 	 	 	We also have an Employee Stock Purchase Plan (ESPP) that allows a payroll deduction of up to 15% of
your salary, subject to certain IRS limitations, to purchase the Company’s stock at a discount of
at least 15% of the market value. The market value used is the lower of the market value at the
beginning or end of each six-month purchase period.
	 
	 	5.	 	Relocation Assistance: In connection with Employee’s execution of this Agreement
Employee shall be provided with relocation assistance (highlighted in the attached Relocation
Policy) to assist with the relocation to, North Carolina. Some of the benefits offered
include:

	 	a.	 	Temporary Housing — Temporary housing will be provided to you for up to three
(3) months with the North Carolina Triangle area. BioCryst will work with you to
locate suitable housing. Should you not need to use the full three (3) months of
temporary housing, Biocryst would pay you the amount of monthly housing ($2,500)
for each full month that you do not use temporary housing, not to exceed three
(3) months in total.

 

 

Peter McCullough

Page Three

December 11, 2009

	 	b.	 	Household Goods — Arrangements with a moving company of BioCryst’s choice will be made to
pack, load and unload your household goods from your current residence to the North Carolina
residence. BioCryst will also include the cost to ship a maximum of one vehicle to North
Carolina.
	 
	 	c.	 	Home Marketing assistance on the sale of your current residence, closing cost reimbursement,
house hunting trips and tax assistance/gross up of costs associated with the move.

	 	6.	 	You will be eligible for vacation during calendar year 2010. These days will accrue at a rate
of 13.33 hours per month (this is 4 weeks on an annual basis). We also observe nine holidays
during the year and allow an additional two floating holidays (1/2 day earned each calendar
quarter) to be used at the employee’s discretion. Any questions concerning our fringe benefit
programs can be directed to Robert Stoner or Mike Richardson.

	 	7.	 	You will be paid a 1 time sign-on bonus of $40,000, subject to the customary deductions and
withholdings as required by law. This signing bonus will be paid to you following 30 days of
active employment. Should you voluntarily separate employment with BioCryst Pharmaceuticals
within 12 months from your start date, you will be required to reimburse the company for the
net amount of the sign-on bonus paid.

Upon joining BioCryst, as a term of your employment, you agree to execute the Company’s standard
nondisclosure agreement. In that agreement, you will confirm, among other things, that
representations previously made to us by you that your employment with BioCryst will not cause you
to breach any fiduciary or other duty, covenant, or understanding to which you are a party or by
terms of which you are bound.

This offer is contingent upon you successfully passing a pre-employment drug
screen, as well as confirmation of your education/experience information, and
a background check. Your employment with BioCryst is for all purposes “at
will,” and this letter does not constitute an employment contract. Instead, it
sets forth the initial terms of your employment with BioCryst.

 

 

Peter McCullough

Page Four

December 11, 2009

All of us at BioCryst look forward to your joining the effort to build the Company into a
sustainable, profitable business engaged in pioneering science. I know that you will be challenged
by this new opportunity and will make significant contributions in the months ahead.

Please indicate that you have read and agree to this letter by signing the original and returning
it to Robert C. Stoner within one week at his Durham, NC office.

	 	 	 	 	 
	 	 	Sincerely,

 	 
	 	  	/s/
Jon P. Stonehouse
 	 
	 	 	Jon P. Stonehouse  	 
	 	 	President and CEO 	 
	 

	 	 	 

	cc:

	 	Robert C. Stoner — VP Human Resources

Stuart Grant — Sr. VP & CFO

	 	 	 	 	 
	Accepted and agreed:

 	 	 
	Name:  	/s/ Peter McCullough 
 	 	 
	 	Peter McCullough 	 

Date: 15 Dec 09

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]